Understand the source comparison
Oxytocin Protocol Comparison: Cycling vs Continuous Dosing
Continuous Daily 10–20 IU once daily, no breaks 55–65% of baseline OXTR 2–4 weeks before tachyphylaxis 2–8°C, 28-day use window Short-term applications, acute interventions Intermittent Cycling 10–20 IU daily for 10–12 days, 4–5 day break 88–92% of baseline OX
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Continuous Daily
- 10–20 IU once daily, no breaks
- 55–65% of baseline OXTR
- 2–4 weeks before tachyphylaxis
- 2–8°C, 28-day use window
- Short-term applications, acute interventions
- Intermittent Cycling
- 10–20 IU daily for 10–12 days, 4–5 day break
- 88–92% of baseline OXTR
- 12+ weeks sustained response
- Long-term social anxiety, bonding protocols
- Pulse Dosing
- 10–20 IU 3× weekly (non-consecutive days)
- 90–95% of baseline OXTR
- Indefinite with proper timing
- 2–8°C, longer shelf stability per vial
- Maintenance therapy, chronic applications
- Pre-Event Acute
- Single 20–40 IU dose 30–45 min before social exposure
- No downregulation (single use)
- Single-event efficacy
- −20°C lyophilized until use
- Performance situations, interviews, public speaking